Selective conditions are required for the induction of invariant NKT cell hyporesponsiveness by antigenic stimulation

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3838-3848

  Wingender, Gerhard ^a,b   Birkholz, Alysia M ^a   Sag, Duygu ^a,b   Farber, Elisa ^c   Chitale, Sampada ^c   Howell, Amy R ^c   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD304 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN FUNCTION; ANTIGEN POTENCY; ANTIGEN STRUCTURE; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BONE MARROW DERIVED DENDRITIC CELL; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER T CELL; NATURAL KILLER T CELL HYPORESPONSIVENESS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; ANIMAL; CYTOLOGY; IMMUNOLOGY; KNOCKOUT MOUSE; TH2 CELL;

ANIMALS; ANTIGENS; B-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; TH1 CELLS; TH2 CELLS;

EID: 84943536756     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500203     Document Type: Article

References (57)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336.
2. Salio, M., J. D. Silk, E. Y. Jones, and V. Cerundolo. 2014. Biology of CD1- and MR1-restricted T cells. Annu. Rev. Immunol. 32:323-366.
3. Rossjohn, J., D. G. Pellicci, O. Patel, L. Gapin, and D. I. Godfrey. 2012. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12:845-857.
4. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877-900.
5. Wingender, G., and M. Kronenberg. 2008. Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G1-G8.
6. Fujii, S., K. Shimizu, M. Kronenberg, and R. M. Steinman. 2002. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat. Immunol. 3:867-874.
7. Parekh, V. V., M. T. Wilson, D. Olivares-Villagómez, A. K. Singh, L. Wu, C.-R. Wang, S. Joyce, and L. Van Kaer. 2005. Glycolipid antigen induces longterm natural killer T cell anergy in mice. J. Clin. Invest. 115:2572-2583.
8. Uldrich, A. P., N. Y. Crowe, K. Kyparissoudis, D. G. Pellicci, Y. Zhan, A. M. Lew, P. Bouillet, A. Strasser, M. J. Smyth, and D. I. Godfrey. 2005. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J. Immunol. 175:3092-3101.
9. Sag, D., P. Krause, C. C. Hedrick, M. Kronenberg, and G. Wingender. 2014. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124:3725-3740.
10. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623-1626.
11. Hochweller, K., J. Striegler, G. J. Hämmerling, and N. Garbi. 2008. A novel CD11c. DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 38:2776-2783.
12. Tyznik, A. J., E. Farber, E. Girardi, A. Birkholz, Y. Li, S. Chitale, R. So, P. Arora, A. Khurana, J. Wang, et al. 2011. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells. Chem. Biol. 18:1620-1630.
13. Wingender, G., P. Rogers, G. Batzer, M. S. Lee, D. Bai, B. Pei, A. Khurana, M. Kronenberg, and A. A. Horner. 2011. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J. Exp. Med. 208:1151-1162.
14. Wingender, G., P. Krebs, B. Beutler, and M. Kronenberg. 2010. Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J. Immunol. 185:2721-2729.
15. Wingender, G., M. Hiss, I. Engel, K. Peukert, K. Ley, H. Haller, M. Kronenberg, and S. von Vietinghoff. 2012. Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. J. Immunol. 188:3000-3008.
16. H2 bias of natural killer T cells. Nature 413:531-534.
17. Schmieg, J., G. Yang, R. W. Franck, and M. Tsuji. 2003. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198:1631-1641.
18. Aspeslagh, S., Y. Li, E. D. Yu, N. Pauwels, M. Trappeniers, E. Girardi, T. Decruy, K. Van Beneden, K. Venken, M. Drennan, et al. 2011. Galactosemodified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J. 30:2294-2305.
19. Patel, O., G. Cameron, D. G. Pellicci, Z. Liu, H.-S. Byun, T. Beddoe, J. McCluskey, R. W. Franck, A. R. Castaño, Y. Harrak, et al. 2011. NKT TCR recognition of CD1d-α-C-galactosylceramide. J. Immunol. 187:4705-4713.
20. Sullivan, B. A., N. A. Nagarajan, G. Wingender, J. Wang, I. Scott, M. Tsuji, R. W. Franck, S. A. Porcelli, D. M. Zajonc, and M. Kronenberg. 2010. Mechanisms for glycolipid antigen-driven cytokine polarization by Va14i NKT cells. J. Immunol. 184:141-153.
21. Wun, K. S., G. Cameron, O. Patel, S. S. Pang, D. G. Pellicci, L. C. Sullivan, S. Keshipeddy, M. H. Young, A. P. Uldrich, M. S. Thakur, et al. 2011. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34:327-339.
22. Wingender, G., B. Schumak, A. Schurich, J. E. Gessner, E. Endl, A. Limmer, and P. A. Knolle. 2006. Rapid and preferential distribution of blood-borne αCD3εAb to the liver is followed by local stimulation of T cells and natural killer T cells. Immunology 117:117-126.
23. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305-334.
24. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650.
25. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985-992.
26. Nagarajan, N. A., and M. Kronenberg. 2007. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178:2706-2713.
27. Tyznik, A. J., E. Tupin, N. A. Nagarajan, M. J. Her, C. A. Benedict, and M. Kronenberg. 2008. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181:4452-4456.
28. Wesley, J. D., M. S. Tessmer, D. Chaukos, and L. Brossay. 2008. NK cell-like behavior of Va14i NK T cells during MCMV infection. PLoS Pathog. 4:e1000106.
29. Tyznik, A. J., S. Verma, Q. Wang, M. Kronenberg, and C. A. Benedict. 2014. Distinct requirements for activation of NKT and NK cells during viral infection. J. Immunol. 192:3676-3685.
30. Holzapfel, K. L., A. J. Tyznik, M. Kronenberg, and K. A. Hogquist. 2014. Antigen-dependent versus-independent activation of invariant NKT cells during infection. J. Immunol. 192:5490-5498.
31. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-525.
32. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529.
33. Porcelli, S. A., and R. L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297-329.
34. Bleicher, P. A., S. P. Balk, S. J. Hagen, R. S. Blumberg, T. J. Flotte, and C. Terhorst. 1990. Expression of murine CD1 on gastrointestinal epithelium. Science 250:679-682.
35. Wei, D. G., H. Lee, S.-H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202:239-248.
36. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426.
37. Arora, P., A. Baena, K. O. A. Yu, N. K. Saini, S. S. Kharkwal, M. F. Goldberg, S. Kunnath-Velayudhan, L. J. Carreño, M. M. Venkataswamy, J. Kim, et al. 2014. A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity 40:105-116.
38. Huang, J.-R., Y.-C. Tsai, Y.-J. Chang, J.-C. Wu, J.-T. Hung, K.-H. Lin, C.-H. Wong, and A. L. Yu. 2014. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3. J. Immunol. 192:1972-1981.
39. Blumenfeld, H. J., R. Tohn, S. M. M. Haeryfar, Y. Liu, P. B. Savage, and T. L. Delovitch. 2011. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 166:121-133.
40. Birkholz, A. M., E. Girardi, G. Wingender, A. Khurana, J. Wang, M. Zhao, S. Zahner, P. A. Illarionov, X. Wen, M. Li, et al. 2015. A novel glycolipid antigen for NKT cells that preferentially induces IFN-γ production. J. Immunol. 195:924-933.
41. Silk, J. D., M. Salio, B. G. Reddy, D. Shepherd, U. Gileadi, J. Brown, S. H. Masri, P. Polzella, G. Ritter, G. S. Besra, et al. 2008. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J. Immunol. 180:6452-6456.
42. Tohn, R., H. Blumenfeld, S. M. M. Haeryfar, N. Veerapen, G. S. Besra, S. A. Porcelli, and T. L. Delovitch. 2011. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes. Clin. Exp. Immunol. 164:26-41.
43. Aspeslagh, S., M. Nemcovic, N. Pauwels, K. Venken, J. Wang, S. Van Calenbergh, D. M. Zajonc, and D. Elewaut. 2013. Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection. J. Immunol. 191:2916-2925.
44. Kim, S., S. Lalani, V. V. Parekh, T. L. Vincent, L. Wu, and L. Van Kaer. 2008. Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J. Clin. Invest. 118:2301-2315.
45. Chiba, A., C. C. Dascher, G. S. Besra, and M. B. Brenner. 2008. Rapid NKT cell responses are self-terminating during the course of microbial infection. J. Immunol. 181:2292-2302.
46. Shimizu, K., Y. Kurosawa, M. Taniguchi, R. M. Steinman, and S. Fujii. 2007. Cross-presentation of glycolipid from tumor cells loaded with aalphagalactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204:2641-2653.
47. Schmieg, J., G. Yang, R. W. Franck, N. Van Rooijen, and M. Tsuji. 2005. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc. Natl. Acad. Sci. USA 102:1127-1132.
48. Bai, L., M. G. Constantinides, S. Y. Thomas, R. Reboulet, F. Meng, F. Koentgen, L. Teyton, P. B. Savage, and A. Bendelac. 2012. Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo. J. Immunol. 188:3053-3061.
49. Bezbradica, J. S., A. K. Stanic, N. Matsuki, H. Bour-Jordan, J. A. Bluestone, J. W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce. 2005. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J. Immunol. 174:4696-4705.
50. Ghosh, S., S. A. Hoselton, and J. M. Schuh. 2012. m-Chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J. Immunol. 189:1322-1329.
51. Macpherson, A. J., A. Lamarre, K. McCoy, G. R. Harriman, B. Odermatt, G. Dougan, H. Hengartner, and R. M. Zinkernagel. 2001. IgA production without m or d chain expression in developing B cells. Nat. Immunol. 2:625-631.
52. reg cells and macrophages in adipose tissue. Nat. Immunol. 16:85-95.
53. Thomas, S. Y., S. T. Scanlon, K. G. Griewank, M. G. Constantinides, A. K. Savage, K. A. Barr, F. Meng, A. D. Luster, and A. Bendelac. 2011. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 208:1179-1188.
54. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11:34-46.
55. Biburger, M., and G. Tiegs. 2008. Activation-induced NKT cell hyporesponsiveness protects from α-galactosylceramide hepatitis and is independent of active transregulatory factors. J. Leukoc. Biol. 84:264-279.
56. Arora, P., M. M. Venkataswamy, A. Baena, G. Bricard, Q. Li, N. Veerapen, R. Ndonye, J.-J. Park, J. H. Lee, K.-C. Seo, et al. 2011. A rapid fluorescencebased assay for classification of iNKT cell activating glycolipids. J. Am. Chem. Soc. 133:5198-5201.
57. Bai, L., Y. Sagiv, Y. Liu, S. Freigang, K. O. Yu, L. Teyton, S. A. Porcelli, P. B. Savage, and A. Bendelac. 2009. Lysosomal recycling terminates CD1dmediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc. Natl. Acad. Sci. USA 106:10254-10259.